{
    "clinical_study": {
        "@rank": "96012", 
        "brief_summary": {
            "textblock": "OBJECTIVES:\n\n      I.   Determine specific clinical features, molecular abnormalities, and laboratory-based\n      biological markers of free radical stress that are associated with amyotrophic lateral\n      sclerosis and influence disease severity."
        }, 
        "brief_title": "Determinants of Disease Severity in Amyotrophic Lateral Sclerosis", 
        "condition": "Amyotrophic Lateral Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Amyotrophic Lateral Sclerosis", 
                "Sclerosis", 
                "Motor Neuron Disease"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: This is a screening and diagnostic study. Blood and urine samples are\n      collected from patients every 2 months for 1 year.  All samples are evaluated for measures\n      of free radical damage and levels of the body's own antioxidant activity."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Clinically diagnosed probable or definite, sporadic or\n        familial amyotrophic lateral sclerosis\n\n        --Patient Characteristics-- Pulmonary: No artificial ventilation required Other: No other\n        neurodegenerative diseases No concurrent or history of unstable medical illness"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "75", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004457", 
            "org_study_id": "199/13650", 
            "secondary_id": [
                "MGH-97-7231", 
                "MGH-1K08NS01896"
            ]
        }, 
        "keyword": [
            "amyotrophic lateral sclerosis", 
            "motor neuron disease", 
            "neurologic and psychiatric disorders", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Merit E. Cudkowicz", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004457"
        }, 
        "source": "Office of Rare Diseases (ORD)", 
        "sponsors": {
            "collaborator": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1998", 
        "study_design": "Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "January 2001"
    }, 
    "geocoordinates": {}
}